Therapure Biopharma is an established Canadian biomanufacturer based in Mississauga that develops and manufactures plasma-derived proteins. Its core technology is the patented PlasmaCap EBAMD expanded-bed absorption system, which the company says is unique globally and can produce more proteins from the same amount of plasma while separating proteins faster and at lower cost than existing processes. The company intends to accelerate the design, development and commercialization of PlasmaCap and to offer a turnkey solution enabling international clients to begin plasma protein separation and reduce reliance on imports. Initially Therapure plans to manufacture two blood proteins at its Mississauga facility: albumin and intravenous immunoglobulin (IVIG). The company expects the project to create 91 direct jobs plus additional employment through its Canadian supply chain. The fundraise described in the articles is a repayable contribution that will support this commercialization and expansion effort.

Total raised

$20M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2015